• Explore /
  • Poster
  • / A single arm phase II study of rucaparib maintenance in patients with advanced pancreatic adenocarcinoma and a known deleterious <em>BRCA1, BRCA2</em> or <em>PALB2</em> mutation who have achieved stability on platinum therapy.

A single arm phase II study of rucaparib maintenance in patients with advanced pancreatic adenocarcinoma and a known deleterious BRCA1, BRCA2 or PALB2 mutation who have achieved stability on platinum therapy.

Abstract Poster

Authors

null

Kim Anna Reiss

University of Pennsylvania, Philadelphia, PA

Kim Anna Reiss , Kara Noelle Maxwell , Katharine Nathanson , Ursina R. Teitelbaum , Mark H. O'Hara , Peter J. O'Dwyer , Charles Schneider , Erica L. Carpenter , Rosemarie Mick , Susan M. Domchek

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Clinical Trial Registration Number

NCT03140670

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr TPS531)

DOI

10.1200/JCO.2018.36.4_suppl.TPS531

Abstract #

TPS531

Poster Bd #

Q7

Abstract Disclosures

Similar Posters

First Author: Wassim Abida

First Author: Anne Patsouris

First Author: Ruben Raychaudhuri

First Author: Kim Anna Reiss